• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Prospective Cohort

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , International active surveillance study of women taking oral contraceptives (INAS-OC). Pharmacoepidemiology and Drug Safety. 2006; 15: S132.
Heinemann Klaas, Saad F, Wiesemes M, Heinemann Lothar A , Expectations towards a novel MFC and potential user types. Results of a multinational survey. J Andrology. 2005; 26(2): 155-62.
Heinemann Klaas, Saad F, Wiesemes M, Heinemann Lothar A , Attitudes toward male fertility control; a multinational survey in four continents. Human Reproduction. 2005; 20 (2): 549-56.
Spannagl M, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8.
Heinemann Lothar A , Dinger Jürgen, Safety of a new oral contraceptive containing drospirenone Drug Safety. 2004; 27(13):1001-18.
Heinemann Klaas, Thiel C, Lewis Michael, Raff T, Heinemann Lothar A , Benign gynecological tumors: estimated incidence. Results of the German Cohort study on Women’s Health Eur J Obst Gyn Reprod Biol. 2003; 107: 78-80.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Garbe E, Lifetime history of oral contraceptive use and development of the uterus and ovary. Geburth Frauenheilk. 2002; 62:566-573. DOI: 10.1055/s-2002-32421.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, The risk of breast tumors and lifetime history of oral contraceptive use Geburtshilfe und Frauenheilkund. 2002; 62(8):750-757.
Heinemann Klaas, Assmann Anita, Lewis Michael, Garbe E, Heinemann Lothar A , Teichmann A T, Trend der HRT Nutzung in Deutschland 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. 2002; 43:508-511.
Heinemann Klaas, Lewis Michael, Assmann Anita, Garbe E, Heinemann Lothar A , Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 Zentralbl Gynakol. 2002; 124(2): 128-131. DOI: 10.1055/s-2002-24241.
Heinemann Lothar A , Assmann Anita, Lewis Michael, How representative can be a cohort of volunteers for the general population? The German Cohort Study on Women' Health. Life and Medical Science Online. 2001; 2.
Suissa S, Spitzer WO, Rainville B, Cusson J , Lewis Michael, Heinemann Lothar A , Recurrent use of newer oral contraceptives and the risk of venous thromboembolism Hum Reprod. 2001; Apr;15(4):817-21.
  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.